Flynn Karen
- SEC CIK
- 0001553599
In the past year, 1 open-market sale filing worth $25.5K and no purchases.
Current role at each company
- STVN Stevanato Group S.p.A.Directoras of Jun 26, 2026
- SHC Sotera Health CoDirectoras of May 27, 2026
- QTRX Quanterix CorpDirectoras of Jan 6, 2026
- CTLT Catalent, Inc.Directoras of Oct 31, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $25.5K
- 1 filing
- Net
- −$25.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Flynn Karen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
STVN Stevanato Group S.p.A.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 (view filing) | Jun 15 | 11 daysLate | Flynn KarenDirector | SSale | −1.49K | $17.09 | −$25.5K | −20.6%5.76K after |
CTLT Catalent, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 11, 2022 (view filing) | Jan 10 | 1 day | Flynn KarenChief Commercial Officer | SSale | −2.47K | $116.64 | −$288.3K | −6.9%33.2K after |